Navigation Links
Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
Date:4/11/2013

(PRWEB) April 11, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, will be exhibiting and presenting at the 2013 Global Formulation and Drug Delivery Summit in Amsterdam, The Netherlands.

Tony Pigeon, one of Patheon’s scientific experts will be present at the show. Tony is the Senior Manager, Global Science and Technology at Patheon. During his more than 30 year career, he has acquired a considerable degree of experience working with big pharmaceuticals and small biotechs. His diverse experience in the field of drug product development ranges from pre-formulation to process validation for a wide range of dosage forms, including tablets, capsules, semi-solids, sterile solution and suspension products, oral solution and suspension products and aerosols.

Other Patheon representatives will also be available to meet at the Global Formulation and Drug Delivery summit exhibit hall from April 23-24, 2013, showcasing several of Patheon’s key service offerings. Learn more by visiting Patheon’s booth during the conference. To schedule a meeting in advance send an email to events(at)patheon(dot)com.

For more information on upcoming events, visit http://www.patheon.com/Knowledge-Library/Events.aspx.

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10619404.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
2. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
3. Patheon to Present at Informex USA
4. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
5. Patheon to Present at 2013 DCAT Week
6. Patheon to Present New Updates in Drug Formulation and Bioavailability
7. NanoLogix Announces Development of Multi-Well, Rapid Diagnostic Test Variant and Exhibits at the American Society for Microbiology General Meeting in San Francisco
8. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
9. Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting
10. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
11. 23andMe Presents Top Ten Most Interesting Genetic Findings of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2020)... ... May 13, 2020 , ... Early stages of drug discovery ... no information on the drug’s mechanism of action (MOA). Gene expression profiling technologies ... the activity of molecular pathways. This information can complement phenotypic readouts and can ...
(Date:5/5/2020)... ... May 05, 2020 , ... ... the launch of its iGlucose® LTE Cat-M Cellular Connected Diabetes Blood ... Cat-M1 technology, the industry’s newest and broadest cellular connectivity available, to provide patients ...
(Date:4/22/2020)... CAMBRIDGE, Mass. (PRWEB) , ... April 20, 2020 ... ... with US offices in Cambridge, MA, announced today that Omixon’s founder and chairman ... early commercialisation of Omixon’s flagship product Holotype HLA since 2014 before stepping into ...
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , ... reached 200,000 SneakPeek Early Gender DNA Tests sold in March, just months ... launched as an ecommerce product, where a mom could order her kit online, collect ...
Breaking Biology Technology:
(Date:5/14/2020)... (PRWEB) , ... May 14, 2020 , ... ... job board for medical sales representatives, found the 2019 average medical sales rep ... findings risk being shadowed by uncertainties amid the COVID-19 global crisis. , The ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory services advisor. The ... companion diagnostics industries. Flagship and Corritori are taking a collaborative approach to empower ...
(Date:4/30/2020)... Del. (PRWEB) , ... April 29, 2020 , ... ... was well positioned for continued growth – delivering innovative solutions for a wide ... care, chemical, aerospace and government agencies. A month into the new decade, it ...
Breaking Biology News(10 mins):